Dr. Costin on Initial Considerations in Early-Stage Lung Cancer

Publication
Video
Supplements and Featured PublicationsMy Treatment Approach: Locally Advanced Lung Cancer
Volume 1
Issue 1

Dan Costin, MD, discusses initial considerations in early-stage lung cancer.

Dan Costin, MD, co-medical director, White Plains Hospital Center for Cancer Care, director, Cancer and Blood Specialists of New York, discusses initial considerations in early-stage lung cancer.

Patients with early-stage lung cancer typically require a multidisciplinary approach to treatment, says Costin. For example, thoracic surgeons, in addition to medical oncologists, will often be involved in initial treatment decisions.

In the early-stage setting, tissue diagnosis and appropriate staging are needed, says Costin. The majority of patients will undergo a CT-guided biopsy or a navigational bronchoscopy to determine tissue diagnosis. For staging, patients typically undergo a PET scan.

For a patient with a confirmed diagnosis of early-stage lung cancer, initial treatment selection is based on factors such as patient comorbidities, surgical eligibility, and results of molecular testing, concludes Costin.

Related Videos
Pasi A. Jänne, MD, PhD, discusses an exploratory analysis from the FLAURA2 trial of osimertinib plus chemotherapy in treatment-naive, EGFR-mutant NSCLC.
Saad J. Kenderian, MB, CHB
Jaime Schneider, MD, PhD
Benjamin Creelan, MD
Neel P. Chudgar, MD
Paul K. Paik, MD, clinical director, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center
Joshua K. Sabari, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine
Raj Singh, MD
Arya Amini, MD
Vlad Gabriel Zaha, MD, PhD